<DOC>
	<DOCNO>NCT01205867</DOCNO>
	<brief_summary>The purpose study investigate safety tolerability AZD8848 Butyrylcholinesterase deficient subject comparison sex age match control subject .</brief_summary>
	<brief_title>Study Investigate Safety Tolerability AZD8848 Butyrylcholinesterase Deficient Subjects</brief_title>
	<detailed_description>An Open , Non-controlled , Non-randomised , Parallel-group Study Investigate Safety , Tolerability , Pharmacokinetics Pharmacodynamics Single Ascending Doses AZD 8848 Administered Intranasally Male Female Butyrylcholinesterase deficient Subjects Sex Age match Controls</detailed_description>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Metabolism , Inborn Errors</mesh_term>
	<criteria>BChE deficient subject : The halflive AZD8848 plasma 20 minute vitro screen test Matched control subject : The halflive AZD8848 plasma le 2 minute vitro screen test Any clinically relevant abnormal finding physical examination , laboratory assessment , vital sign ECG Present medical history cardiovascular disease , opinion investigator , may either put subject risk participation study influence result study subject 's ability participate study Family history autoimmune disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Butyrylcholinesterase deficiency</keyword>
	<keyword>tolerability</keyword>
	<keyword>safety</keyword>
	<keyword>AZD8848</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>pharmacodynamics</keyword>
	<keyword>BChE deficient subject match control subject</keyword>
</DOC>